» Articles » PMID: 20015543

The Development of a Three-dimensional Scaffold for Ex Vivo Biomimicry of Human Acute Myeloid Leukaemia

Overview
Journal Biomaterials
Date 2009 Dec 18
PMID 20015543
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Acute myeloid leukaemia (AML) is a cancer of haematopoietic cells that develops in three-dimensional (3-D) bone marrow niches in vivo. The study of AML has been hampered by lack of appropriate ex vivo models that mimic this microenvironment. We hypothesised that fabrication and optimisation of suitable biomimetic scaffolds for culturing leukaemic cells ex vivo might facilitate the study of AML in its native 3-D niche. We evaluated the growth of three leukaemia subtype-specific cell lines, K-562, HL60 and Kasumi-6, on highly porous scaffolds fabricated from biodegradable and non-biodegradable polymeric materials, such as poly (L-lactic-co-glycolic acid) (PLGA), polyurethane (PU), poly (methyl-methacrylate), poly (D, L-lactade), poly (caprolactone), and polystyrene. Our results show that PLGA and PU supported the best seeding efficiency and leukaemic growth. Furthermore, the PLGA and PU scaffolds were coated with extracellular matrix (ECM) proteins, collagen type I (62.5 or 125 microg/ml) and fibronectin (25 or 50 microg/ml) to provide biorecognition signals. The 3 leukaemia subtype-specific lines grew best on PU scaffolds coated with 62.5 microg/ml collagen type I over 6 weeks in the absence of exogenous growth factors. In conclusion, PU-collagen scaffolds may provide a practical model to study the biology and treatment of primary AML in an ex vivo mimicry.

Citing Articles

Intracellular Biomacromolecule Delivery by Stimuli-Responsive Protein Vesicles Loaded by Hydrophobic Ion Pairing.

Gray M, de Janon A, Seeler M, Heller W, Panoskaltsis N, Mantalaris A ACS Omega. 2025; 10(3):2628-2639.

PMID: 39895718 PMC: 11780410. DOI: 10.1021/acsomega.4c07666.


culture of leukemic cells in collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel.

Svozilova H, Vojtova L, Matulova J, Bruknerova J, Polakova V, Radova L PeerJ. 2024; 12:e18637.

PMID: 39655330 PMC: 11627079. DOI: 10.7717/peerj.18637.


Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.

Stevens A, Terrell M, Rashid R, Fisher K, Marcogliese A, Gaikwad A Biomedicines. 2024; 12(2).

PMID: 38397996 PMC: 10886789. DOI: 10.3390/biomedicines12020394.


Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system.

Alhattab D, Isaioglou I, Alshehri S, Khan Z, Susapto H, Li Y Biomater Res. 2023; 27(1):111.

PMID: 37932837 PMC: 10626721. DOI: 10.1186/s40824-023-00457-9.


CXCL chemokines-mediated communication between macrophages and BMSCs on titanium surface promotes osteogenesis via the actin cytoskeleton pathway.

Zhang Y, Wei J, Yu X, Chen L, Ren R, Dong Y Mater Today Bio. 2023; 23:100816.

PMID: 37859997 PMC: 10582501. DOI: 10.1016/j.mtbio.2023.100816.